Paediatric cataract initiative names global advisory council

Article

The Pediatric Cataract Initiative ( ), sponsored by the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation, has announced its inaugural global advisory council.

The Pediatric Cataract Initiative (www.PaediatricCataract.org ), sponsored by the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation, has announced its inaugural global advisory council. Members include:

Gullapalli “Nag” Rao, M.D., MBBS, Ph.D. (Board Chairman). Dr Rao is an internationally recognized ophthalmologist and founder of the L V Prasad Eye Institute (Hyderabad, India). He is known worldwide for his humanitarian efforts to prevent blindness.

Joseph Barr, O.D., MS, FAAO. Dr Barr is vice president of Global Clinical & Medical Affairs and Professional Services (Vision Care) for Bausch + Lomb (Rochester, N.Y.). He is an emeritus professor of Optometry and Vision Science at The Ohio State University, and the emeritus editor of Contact Lens Spectrum.

Dr Sean P. Donahue, Ph.D. Dr Donahue is professor of Ophthalmology and Visual Sciences at Vanderbilt University Medical Center (Nashville, Tenn.). He is currently the chief of paediatric ophthalmology at Monroe Carell Jr Children’s Hospital at Vanderbilt with a special interest in early diagnosis of correctable childhood eye problems.

Dr Clare Gilbert, MSc. Dr Gilbert is professor of International Eye Health at the International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London University (UK). Her research focuses on the epidemiology of blindness in children, particularly in low-to middle-income countries.

Dr Scott Lambert, Dr Lambert is the R. Howard Dobbs professor of Ophthalmology and Pediatrics at Emory University (Atlanta, Ga.). His specialty is paediatric cataracts; he is currently chairing a National Institutes of Health clinical trial on the best way to optically correct infants after cataract surgery.

Dr Lipika Roy, MBA. Dr Roy is head of Asia-Pacific Medical Affairs (Pharmaceuticals) for Bausch + Lomb (Singapore). A paediatric ophthalmologist, she was formerly the assistant director of research, ophthalmology, for Singapore's National Health Care Group.

In addition, Lions Clubs International Foundation will name one of its members to serve on the advisory board in July 2010.

The Paediatric Cataract Initiative will use the resources of the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation to identify, fund and promote innovative methods of overcoming this issue for the long-term benefit of children, their families and their communities.

This debilitating childhood condition is a clouding of the eye's natural lens. Causes include intrauterine infections such as pregnancy rubella, metabolic disorders and genetically transmitted syndromes.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.